Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice

[1]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[2]  W. Griffin.  Faculty Opinions recommendation of Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. , 2012 .

[3]  S. Barger,et al.  Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors , 2011, Journal of Neuroinflammation.

[4]  M. O’Banion,et al.  Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice , 2011, Journal of Neuroinflammation.

[5]  S. Allan,et al.  Assessing the contribution of inflammation in models of Alzheimer's disease. , 2011, Biochemical Society transactions.

[6]  V. Perry,et al.  Proinflammatory cytokines, sickness behavior, and Alzheimer disease , 2011, Neurology.

[7]  R. Green,et al.  Extended results of the Alzheimer’s disease anti-inflammatory prevention trial , 2011, Alzheimer's & Dementia.

[8]  Je-Hyun Yoon,et al.  Daxx mediates activation‐induced cell death in microglia by triggering MST1 signalling , 2011, The EMBO journal.

[9]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[10]  Karl Herrup,et al.  Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.

[11]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[12]  G. Münch,et al.  Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles? , 2010, Mutation research.

[13]  I. Knuesel.  Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases , 2010, Progress in Neurobiology.

[14]  S. Pimplikar,et al.  APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation , 2010, PloS one.

[15]  R. Nitsch,et al.  Reduced Reelin Expression Accelerates Amyloid-β Plaque Formation and Tau Pathology in Transgenic Alzheimer's Disease Mice , 2010, The Journal of Neuroscience.

[16]  V. Perry,et al.  Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.

[17]  N. Zawia,et al.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases , 2009, Molecular Psychiatry.

[18]  A. Volterra,et al.  Astrocytic dysfunction: Insights on the role in neurodegeneration , 2009, Brain Research Bulletin.

[19]  R. Carare,et al.  Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease , 2009, Alzheimer's Research & Therapy.

[20]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[21]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[22]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[23]  H. Braak,et al.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.

[24]  J. Feldon,et al.  Age-related accumulation of Reelin in amyloid-like deposits , 2009, Neurobiology of Aging.

[25]  Martin Rossor,et al.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study , 2008, Neurobiology of Disease.

[26]  H. Anisman,et al.  Influence of continuous infusion of interleukin-1β on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression , 2008, Psychopharmacology.

[27]  C. France,et al.  Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception , 2008, Psychopharmacology.

[28]  Urs Meyer,et al.  Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice , 2008, Brain, Behavior, and Immunity.

[29]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[30]  H. Lester,et al.  Rodent Aβ Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic Mice* , 2007, Journal of Biological Chemistry.

[31]  Ralf Hoffmann,et al.  Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. , 2007, Biochemical and biophysical research communications.

[32]  Colm Cunningham,et al.  The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.

[33]  N. Robakis,et al.  It May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease , 2007, Neurodegenerative Diseases.

[34]  H. Soininen,et al.  Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[35]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[36]  Inga Kadish,et al.  Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice , 2006, Neurobiology of Disease.

[37]  Urs Meyer,et al.  The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology , 2006, The Journal of Neuroscience.

[38]  L. Thal,et al.  A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.

[39]  R. Mrak,et al.  Glia and their cytokines in progression of neurodegeneration , 2005, Neurobiology of Aging.

[40]  W. Streit,et al.  Microglia and Alzheimer's disease pathogenesis , 2004, Journal of neuroscience research.

[41]  A. Hofman,et al.  Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.

[42]  W. Streit,et al.  Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes , 2004, Glia.

[43]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[44]  K. Davis,et al.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. , 2003, JAMA.

[45]  S. Barger,et al.  Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway , 2003, The Journal of Neuroscience.

[46]  Rena Li,et al.  Microglia and inflammatory mechanisms in the clearance of amyloid β peptide , 2002 .

[47]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[48]  David M. Bannerman,et al.  Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery , 2002, Behavioural Brain Research.

[49]  J. Sanes,et al.  Increased vulnerability to kainate‐induced seizures in utrophin‐knockout mice , 2002, The European journal of neuroscience.

[50]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[51]  B. Thisse,et al.  Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptor-dependent invasive process. , 2001, Developmental biology.

[52]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[53]  C. Colton,et al.  Microglial Contribution to Oxidative Stress in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[54]  W. Staines,et al.  Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[55]  M. Goedert,et al.  Tau protein pathology in neurodegenerative diseases , 1998, Trends in Neurosciences.

[56]  L. Lue,et al.  Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.

[57]  R. Skinner,et al.  In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis , 1996, Neurobiology of Aging.

[58]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[59]  P. Greengard,et al.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[61]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Pimplikar,et al.  Detection of APP intracellular domain in brain tissue. , 2011, Methods in molecular biology.

[63]  P. Mcgeer,et al.  Local neuroinflammation and the progression of Alzheimer’s disease , 2011, Journal of NeuroVirology.

[64]  I. Knuesel,et al.  Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice. , 2010, Journal of Alzheimer's disease : JAD.

[65]  John Q Trojanowski,et al.  Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. , 2008, Journal of Alzheimer's disease : JAD.

[66]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[67]  B. Zlokovic,et al.  The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.

[68]  Rena Li,et al.  Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. , 2002, Glia.